The existing pharmacological treatment options for chronic pain, epilepsy, Parkinson's disease (PD), and depression may not be effective for people at different stages of treatment. In the US alone, about 5.1 million people were diagnosed with epilepsy or seizure disorder in 2013. Though the existing options like drug therapy, physiotherapy,and surgeries are effective in treating these disorders, but they do not suit for the entire patient population. Neurostimulation is a potential alternative for individuals who do not respond to drug therapy or surgeries.In this report, Technavio covers the present scenario and growth prospects of the global VNS market for 2016-2021 (base year: 2016; forecast end year: 2021).

PART 01: Executive summary 5

PART 02: Scope of the report 16

Market overview 16

Top-vendor offerings 17

PART 03: Market research methodology 18

Research methodology 18

Economic indicators 18

PART 04: Introduction 19

Key market highlights 19

PART 05: Market landscape 21

Market overview 21

Market size and forecast 22

Five forces analysis 24

PART 06: Market segmentation by product 25

Implantable VNS devices 25

External VNS devices 28

PART 07: Market segmentation by end-user 31

PART 08: Geographical segmentation 34

VNS market in Americas 34

VNS market in EMEA 36

VNS market in APAC 38

PART 09: Market drivers 40

Increasing prevalence of neurological disorders 40

Favorable reimbursement and insurance approval

policies 40

Rising demand for external VNS devices 41

PART 10: Impact of drivers 42

PART 11: Market challenges 43

Stringent regulatory approvals and high cost of

devices 43

Complications related to VNS 43

High maintenance and low battery lifetime 44

PART 12: Impact of drivers and challenges 45

PART 13: Market trends 46

Shift of surgeons focus toward minimally invasive VNS

procedures 46

Next-generation therapies for nervous system

disorders 47

Application of VNS in other indications 47

PART 14: Vendor landscape 48

Competitive scenario 48

PART 15: Key vendor analysis 50

LivaNova 50

Enteromedics 53

ElectroCore 56

Key company to watch 58

Cerbomed 58

Other prominent vendors 59

PART 16: Appendix 60

List of abbreviations 60

PART 17: Explore Technavio 61